As APOE4-associated neuroinflammatory effects are known to be partially mediated by microglia [33], we also tested whether microglial activation was associated with APOE4 carriership in COVID-19; however, there was no such association (Fig. 4, p > 0.05 in all studied brain areas). This evidence concerns the gene APOE and COVID-19.